Newcleo

50Mixed / Improving· Provisional
0 followersNuclear / SMR·Paris, France·Founded 2021
www.newcleo.com/

Newcleo is developing MOX-fuelled lead-cooled fast reactors to generate low-carbon power while consuming nuclear waste, with a prototype 30 MWe reactor planned in France and over €537m raised.

50/100
Mixed / Improving· Provisional

ClimateTicker Green Score · how it's calculated

Greenwashing risk: mediumData confidence: medium

Why it's on ClimateTicker

Newcleo is developing Gen-IV lead-cooled fast reactors fuelled by MOX derived from reprocessed spent nuclear fuel, a technology that — if commercialised — would generate near-zero-carbon baseload power while consuming existing nuclear waste stockpiles, genuinely cutting long-run emissions and waste burdens. The core thesis is credible in principle: nuclear lifecycle emissions are among the lowest of any power source, and closing the fuel cycle addresses a real problem. However, Newcleo remains entirely pre-revenue on its reactor business, no reactor has been built, and the 2032 first-criticality target depends on regulatory approvals, licensing milestones, and a MOX plant that are both still in early stages — meaning the climate impact is a future promise, not a demonstrated reality.

mitigationNewcleo generates current revenue (~$80M in 2024) through nuclear supply-chain engineering and equipment subsidiaries acquired to support vertical integration; its primary future business model is designing, building, and operating MOX-fuelled lead-cooled fast reactors (starting with a 30 MWe demonstrator in France, scaling to 200 MWe commercial units) and manufacturing MOX fuel, targeting energy-intensive industries such as steel, shipping, and chemicals as offtakers.

Controversy & Greenwashing Watch

lowNo published sustainability report or GHG disclosure

Despite raising over $780M in private capital and employing 900+ people, Newcleo has published no independently verified sustainability report, emissions inventory, or CDP disclosure, leaving climate claims unverifiable by third parties.source ↗

mediumPre-revenue SPAC listing at $2.4B valuation

Newcleo announced a SPAC merger (May 2026) targeting a $2.4B valuation despite having no operating reactor, no MOX plant, and reactor first criticality not expected before 2032, raising investor risk and potential hype-cycle concerns.source ↗

mediumNuclear reprocessing proliferation risk

Independent nonproliferation experts and environmental advocates have broadly warned that MOX reprocessing facilities — the type Newcleo is building — can create pathways for weapons-grade plutonium diversion, a systemic risk the company is mitigating through Euratom safeguards-by-design engagement but has not eliminated.source ↗

mediumInterdependent reactor and MOX plant licensing risk

Newcleo has explicitly told French regulators that its 30 MWe LFR reactor and the MOX fuel fabrication plant are 'interdependent projects' — if either fails licensing, both collapse, creating a binary execution risk that could delay or permanently defer climate impact.source ↗

Community Reviews

No reviews yet. Be the first to share your experience!